Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	MK-0736 0.5 mg	137
Overall Study	STARTED	MK-0736 2.0 mg	134
Overall Study	STARTED	MK-0736 8.0 mg	141
Overall Study	STARTED	HCTZ 12.5 mg → MK-0736 8.0 mg	71
Overall Study	STARTED	Placebo	137
Overall Study	COMPLETED	MK-0736 0.5 mg	105
Overall Study	COMPLETED	MK-0736 2.0 mg	103
Overall Study	COMPLETED	MK-0736 8.0 mg	109
Overall Study	COMPLETED	HCTZ 12.5 mg → MK-0736 8.0 mg	56
Overall Study	COMPLETED	Placebo	106
Overall Study	NOT COMPLETED	MK-0736 0.5 mg	32
Overall Study	NOT COMPLETED	MK-0736 2.0 mg	31
Overall Study	NOT COMPLETED	MK-0736 8.0 mg	32
Overall Study	NOT COMPLETED	HCTZ 12.5 mg → MK-0736 8.0 mg	15
Overall Study	NOT COMPLETED	Placebo	31

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00806585/flow